Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model

Calibrated Automated Thrombin Generation Measurement in Clotting Plasma

H.C. Hemker, Peter Giesen, Raed Al Dieri et al. · Pathophysiology of Haemostasis and Thrombosis · 2003 · 1.4K citations · Full text

Medicine, Hematology, Good Laboratory Practice +16

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

Elise S. Eerenberg, Pieter W. Kamphuisen, Meertien K. Sijpkens et al. · Circulation · 2011 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

L. Samüel Wann, Anne B. Curtis, Craig T. January et al. · Circulation · 2010 · 1.3K citations · Full text

Medicine, Cardiology, Clinical Cardiology +11

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

Joachim Stangier, Karin Rathgen, Hildegard Stähle et al. · British Journal of Clinical Pharmacology · 2007 · 884 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban

Raphaël Marlu, Enkelejda Hodaj, Pierre Albaladéjo et al. · Thrombosis and Haemostasis · 2012 · 502 citations

Medicine, Pharmacology, Pharmacotherapy +17